Chester County News and Community Website
WARMINSTER, PA and OXFORD, United Kingdom — Arbutus Biopharma Corporation and Barinthus Biotherapeutics recently unveiled encouraging preliminary results from their Phase 2a IM-PROVE II clinical trial at the American Association …
Promising New Data from Hepatitis B Trial by Arbutus and Barinthus Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has shared its latest business updates and unaudited financial results for the third quarter ending September 30, 2024. The company is advancing …
Traws Pharma Reports Q3 Financials and Updates on Clinical Advances Read More
NEWTOWN, PA — CenTrak has announced the appointment of Steffi Thorlichen as its new Chief Customer Experience Officer (CXO). With a robust background spanning 25 years in global customer management, …
CenTrak Appoints Steffi Thorlichen as Chief Customer Experience Officer Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a significant leadership change as Craig Fraser steps down from his role as Chief Executive Officer, effective December 1, 2024. …
Leadership Transition at Windtree Therapeutics: Fraser Retires, Latkin Takes Helm Read More WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced its participation in the upcoming Jefferies London Healthcare Conference, where the Company will host a fireside chat and one-on-one meetings with …
Arbutus Biopharma to Showcase Innovations at Jefferies London Healthcare Conference Read More
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has reported a remarkable third quarter in 2024, achieving a record revenue of $2.94 million. This represents a 141% increase from the same …
NEXGEL Achieves Record Revenue in Q3 2024 with Promising Growth Outlook Read MoreNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) this week announced its third quarter financial results for 2024, alongside significant updates on its clinical programs. The company is …
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has released its financial results for the third quarter of 2024, revealing an increase in net revenue from its flagship product, XHANCE, and adjustments …
Optinose Reports Q3 2024 Financial Results, Highlights XHANCE Performance Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) is set to release its financial results for the third quarter of 2024 today after the market closes. Following the announcement, the company …
NEXGEL, Inc. Announces Third Quarter 2024 Financial Results Release and Conference Call Read More
LANGHORNE, PA – Savara Inc. (Nasdaq: SVRA) announced that its management team will be featured in a fireside chat at the prestigious Guggenheim Inaugural Healthcare Conference on November 12, 2024, …
Savara Inc. to Participate in Guggenheim Inaugural Healthcare Conference Read More